Back to Market Feed

BORTEZOMIB 3.5 MG VIAL

BORTEZOMIB
$43.3460per EA

Strength

3.5 mg/1

Manufacturer

Eugia US LLC

NDC

55150033701

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

3/19/2025

Active Ingredients

BORTEZOMIB

Approval Type

Generic (ANDA)

FDA Application

ANDA212825

On Market Since

5/2/2022

Pharmacological Classes

Proteasome Inhibitor
Proteasome Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+46.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

BORTEZOMIB 3.5 MG VIAL
Generic
00143909801•Hikma Pharmaceuticals USA Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
00409170001•Hospira Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
31722030331•Camber Pharmaceuticals Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
43598042660•Dr. Reddy's Laboratories Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
50742048401•Ingenus Pharmaceuticals LLC
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
60505605004•Apotex Corp.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
63323082110•Fresenius Kabi USA, LLC
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001053436•BluePoint Laboratories
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001054036•BluePoint Laboratories
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001054136•BluePoint Laboratories
$43.3460
per EA